Literature DB >> 12546565

3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).

Tao Peng1, Jianfeng Pei, Jiaju Zhou.   

Abstract

A set of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors was investigated with the aim of developing 3D-QSAR models using the Flexible Atom Receptor Model (FLARM) method. Some 3D-QSAR models were built with high correlation coefficients, and the FLARM method predicted the biological activities of compounds in test set well. The FLARM method also gave the pseudoreceptor model, which indicates the possible interactions between the receptor and the ligand. The possible interactions include two hydrogen bonds, one hydrophobic interaction, and one sulfur-aromatic interaction, which are in accord with those in the pharmacophore model given by the scientists at Novartis. This shows that the FLARM method can bridge 3D-QSAR and receptor modeling in computer-aided drug design. Pharmacophore can be obtained according to these results, and 3D searching can then be done with databases to find the lead compound of EGFR tyrosine kinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12546565     DOI: 10.1021/ci0256034

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  3 in total

1.  Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.

Authors:  Xian-qiang Sun; Lei Chen; Yao-zong Li; Wei-hua Li; Gui-xia Liu; Yao-quan Tu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

Review 2.  Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Firoza Rahman; Md Saidur Rahaman; Md Shajib Khan; Sayedul Abrar; Tanmay Kumar Ray; Mohammad Borhan Uddin; Most Sumaiya Khatun Kali; Kamal Dua; Mohammad Amjad Kamal; Dinesh Kumar Chellappan
Journal:  Bioengineering (Basel)       Date:  2022-07-25

Review 3.  In silico pharmacology for drug discovery: applications to targets and beyond.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.